Warfarin for thromboprophylaxis following total joint arthroplasty: Are patients safely anti-coagulated?

Journal of Arthroplasty

Volumn 28, Issue 8, 2013, Pages 1251-1253

  Aynardi, Michael ^a   Brown, P Benedict ^a   Post, Zachary ^a   Orozco, Fabio ^a   Ong, Alvin ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Complications; International normalized ratio (INR); Joint replacement; Thromboprophylaxis; Warfarin

Indexed keywords

WARFARIN;

ARTHROPLASTY; ARTICLE; BLEEDING; CELLULITIS; DEEP VEIN THROMBOSIS; DRUG USE; FEMALE; FRACTURE; HEART INFARCTION; HEMATOMA; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PERONEUS NERVE PARALYSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; THROMBOSIS PREVENTION;

COMPLICATIONS; INTERNATIONAL NORMALIZED RATIO (INR); JOINT REPLACEMENT; THROMBOPROPHYLAXIS; WARFARIN;

AGE FACTORS; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; PATIENT DISCHARGE; PATIENT READMISSION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; THROMBOSIS; WARFARIN;

EID: 84883229150     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2012.12.007     Document Type: Article

References (18)

1. Harris W.H., Sledge C.B. Total hip and knee replacement. N Engl J Med 1990, 323:725.
2. Johanson N.A., Lachiewicz P.F., Lieberman J.R., et al. American Academy of Orthopaedic Surgeons. Clinical Practice Guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg 2009, 17:183.
3. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008, 133(Suppl):381S.
4. Pulido L., Ghanem E., Joshi A., et al. Periprosthetic Joint Infection: The Incidence, Timing, and Predisposing Factors. Clin Orthop Relat Res 2008, 466(7):1710.
5. Parvizi J., Ghanem E., Joshi A., et al. Dose "Excessive" Anticoagulation Predispose to Periprosthetic Infection?. J Arthroplasty 2007, 22(6):24.
6. Amstutz H.C., Friscia D.A., Dorey F., et al. Warfarin prophylaxis to prevent mortality form pulmonary embolism after total hip replacement. J Bone Joint Surg Am 1989, 71:321.
7. Ansell J., Hirsh J., Hylek E., et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008, 133(Suppl):160S.
8. Anderson D.R., Wilson J., Blundell J., et al. Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep vein thrombosis after arthroplasty. J Bone Joint Am 2002, 84:1992.
9. Asnis P., Gardner M., Ranawat A., et al. The Effectiveness of Warfarin Dosing from a Nomogram Compared with House Staff Dosing. J Arthroplasty 2007, 8:213.
10. Xing K., et al. Has the Incidence of Deep Vein Thrombosis in Patients Undergoing Total Hip/Knee Arthroplasty Changed Over Time? A Systematic Review of Randomized Controlled Trials. Thromb Res 2008, 123:24.
11. Freedman K.B., Brookenthal K.R., Fitzgerald R.H., et al. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am 2000, 82:929.
12. Husted H., Holm G. Predictors of Length of Stay and Patients Satisfaction after Hip and Knee Replacement Surgery: Fast Track Experience in 712 Patients. Acta Orthop 2008, 79(20):168.
13. Pulido L., Parvizi J., Macgibeny M., et al. In Hospital Complications After Total Joint Arthroplasty. J Arthroplasty 2008, 23(6):139.
14. Colwell C.W., Berkowitz S.D., Lieberman J.R., et al. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am 2005, 87:2169.
15. Hirsh J., Fuster V., Ansell J., et al. American Heart Association/American College of Cardiology Foundation Guide to warfarin therapy. Circulation 2003, 107:1692.
16. Hansen P., Zmistowski B., Restrepo C., et al. Does International Normalized Ratio Level Predict Pulmonary Embolism?. Clin Orthop Relat Res 2012, 470:547.
17. Dager W. Warfarin for Venous Thromboembolism Prophylaxis After Elective Hip or Knee Arthroplasty: Exploring the Evidence, Guidelines, and Challenges Remaining. Ann Pharmacother 2012, 46:79.
18. Botteman M., et al. Results of an Economic Model to Assess the Cost-Effectiveness of Enoxaparin, a Low-Molecular-Weight Heparin, Versus Warfarin for the Prophylaxis of Deep Vein Thrombosis and Associated Long-Term Complications in Total Hip Replacement Surgery in the United States. Clin Ther 2002, 24:1960.